anthony b evnin phd executive profile  biography  bloomberg july    am et capital markets company overview of venrock snapshotpeople  overviewboard memberscommittees executive profile anthony b evnin phdpartner venrockagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationships background dr anthony b evnin also known as tony phd is a partner of venrock dr evnin is a part of venture development team dr evnin joined venrock in  dr evnin focuses on investments in biotechnology and medical devices he has built venrocks healthcare franchise helping to shape the modern biotechnology industry he has been managing general partner of venrock associates since  he has been a general partner since  and as a managing general partner  since  dr evnin has been director of cantel medical corp since january   he also serves as the director of evotec us inc he joined venrock associates in  and served as its general partner since  dr evnin started his career as a research scientist and group leader in organic chemistry at union carbide and as a business development manager and director of product development at story chemical he served as the chairman of aveo pharmaceuticals inc and has been its director march  he served as the chairman of bostonpower inc since january  dr evnin has been a director of aveo pharmaceuticals inc since march  coley pharmaceutical group inc since august  and renovis inc since july  he serves as a director at agridyne technologies inc arris pharmaceutical corporation escalon medical corp and kopin corporation he has been director of biogen idec hemophilia inc since april  dr evnin has been a director at juno therapeutics inc since january   he serves as a member of advisory board of pelion venture partners dr evnin is a trustee emeritus of princeton university and a trustee of the rockefeller university he serves as trustee of the jackson laboratory as a member of the boards of overseers and managers of memorial sloankettering cancer center as a member of the board of directors of the new york genome center as a member of the board of directors of the albert and mary lasker foundation he has been a director of genetics institute llc since  dr evnin serves on the boards of acceleron pharma inc ribozyme pharmaceuticals inc constellation pharmaceuticals inc and several private companies including idun pharmaceuticals inc he serves as a member of the board of directors of kallyope inc he served as lead director of infinity pharmaceuticals inc and has been its director since september  he served as a director of altea therapeutics corporation dr evnin served as a director of netgenics inc since june  he served as an independent director of sunesis pharmaceuticals inc from  to april   he served as director of memory pharmaceuticals corp since december  he served as a director of cymabay therapeutics inc until september   he served as a director of pacific biosciences of california inc since july  he served as director at bostonpower inc since january  he served as an independent director of pharmos corp from october   to october   he served as a director of icagen inc from may  to october   he served as a director of triangle pharmaceuticals inc since november  and janssen biotech inc since  he served as a director of vela pharmaceuticals inc and celladon corporation dr evnin served as director of axys pharmaceuticals inc caliper life sciences inc since june  and opta food ingredients inc he served as a director of otix global inc from  to october   he served as director of athena neurosciences idec pharmaceuticals idexx laboratories sugen inc and sepracor he has led financing of many biotech companies over the last  years six of his portfolio companies have entered the public market in the last three years and over  of his investments have been through an initial public offering during his venrock tenure he has focused on building valuable companies that address important medical needs of the world while providing strong returns for investors he received a phd in chemistry from the massachusetts institute of technology and an ab in chemistry from the princeton universityread full background corporate headquarters  fifth avenuenew york new york united statesphone fax  board members memberships directoridun pharmaceuticals inctrusteerockefeller universitydirectorconstellation pharmaceuticals incmember of the board of directorskallyope incpresentdirectorgenetics institute llcpresentdirectorbiogen hemophilia incpresentdirectorevotec us incpresentdirectoraveo pharmaceuticals incpresentdirectorinfinity pharmaceuticals incpresentdirectorcantel medical corp education ba princeton universityphd massachusetts institute of technology other affiliations pelion venture partnerscaliper life sciences incjanssen biotech inccoley pharmaceutical group incgenetics institute llcicagen inc prior to merger with xrpro sciences incidun pharmaceuticals incmemory pharmaceuticals corpcymabay therapeutics incnetgenics incotix global incsunesis pharmaceuticals inctriangle pharmaceuticals incbiogen hemophilia inccantel medical corppharmos corpvela pharmaceuticals incevotec us incinfinity pharmaceuticals incaltea therapeutics corporationaveo pharmaceuticals incvenrock iii lpprinceton universitymassachusetts institute of technologyrockefeller universityvenrock iv lpacceleron pharma incpacific biosciences of california inccelladon corporationbostonpower incvenrock v lpconstellation pharmaceuticals incvenrock i lpjuno therapeutics inckallyope inc annual compensation there is no annual compensation data available stocks options there is no stock options data available total compensation there is no total compensation data available request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact venrock please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close tony evnin  venrock active investments constellation pharma — private constellation pharmaceuticals discovers and develops novel drugs targeting selective regulators of epigenetic function acceleron pharma — public nasdaq xlrn acceleron is a biopharmaceutical company developing drugs for important unmet medical needs through proprietary approaches that exploit the therapeutic… celladon corporation — public nasdaq cldn celladon is developing a unique therapeutics platform to treat severe heart failure cymabay therapeutics — public otcqb cyma cymabay therapeutics discovers and develops small molecule drugs for the treatment of diabetes and related metabolic disorders aveo pharma — public nasdaq aveo aveo pharmaceuticals develops therapies for cancer using proprietary genetic model systems that enable the identification of essential targets critical… infinity pharma — public nasdaq infi infinity pharmaceuticals is a drug discovery company that is developing and integrating unique approaches and capabilities in synthetic chemistry chemical… alumni investments coley pharma — acquired by pfizer coley pharmaceutical group discovers develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancers… renovis — acquired by evotec renovis is a biopharmaceutical company focusing on neurological and psychiatric diseases and disorders using a combination of novel genomics and cellbased… memory pharma — acquired by roche memory pharmaceuticals develops small molecule therapeutics for memoryrelated neurological diseases and for psychiatric indications icagen — acquired by pfizer icagen discovers and develops small molecule therapeutics that target ion channels for treatment of a variety of diseases caliper — public nasdaq calp caliper life sciences develops microfluidic technologies to integrate complex laboratory procedures on a microchip for analytical instruments diagnostics… sonic innovations — acquired by william demant holding sonic innovations designs develops manufactures and markets advanced digital hearing aids designed to provide the highest levels of satisfaction for… triangle pharma — acquired by gilead triangle pharmaceuticals provided antiviral and oncology licensing sugen — acquired by pharmacia  upjohn sugen developed novel therapeutics through receptorbased approaches to drug discovery primarily involving kinases and phosphatases athena neurosciences — acquired by elan athena neurosciences manufactured diagnostic and therapeutic products for diseases of the nervous system idec pharma — acquired by biogen idec pharmaceuticals focuses on the commercialization and development of targeted therapies for the treatment of cancer and autoimmune diseases sepracor — public nasdaq sepr sepracor is a researchbased pharmaceutical company dedicated to treating and preventing human disease by discovering developing and commercializing… idexx labs — public nasdaq idxx … centocor — acquired by johnson  johnson centocor is an integrated biopharmaceutical company developing monoclonal antibodybased products for cardiovascular and autoimmune diseases cancer and… genetics institute — acquired by wyeth genetics institute developed pharmaceuticals based on leading edge functional genomics technologies and proprietary disease models to treat a wide variety of human disease conditions tony evnin partner focus areas biotechnology medical devices location new york focus areas biotechnology medical devices location new york tony joined venrock in  and built the firm’s healthcare franchise helping to shape the modern biotechnology industry he currently serves on the board of directors of two public companies aveo pharmaceuticals nasdaq aveo and infinity pharmaceuticals nasdaq infi as well as on the board of directors of constellation pharmaceuticals a private company past investments include acceleron nasdaq xlrn celladon nasdaq cldn centocor ipo acquired by johnson  johnson coley pharmaceutical group ipo acquired by pfizer genetics institute ipo acquired by wyeth icagen ipo acquired by pfizer idec pharmaceuticals ipo merged with biogen idexx laboratories nasdaq idxx millennium pharmaceuticals ipoacquired by takeda and sepracor ipoacquired by dainippon sumitomo more than  of his investments have been through an ipo during his venrock tenure tony started his career as a research scientist and group leader in organic chemistry at union carbide and as director of product development at story chemical he serves as a trustee of the rockefeller university as a trustee of the jackson laboratory as a member of the boards of overseers and managers of memorial sloankettering cancer center as a director of the new york genome center as a member of the board of directors of the albert and mary lasker foundation and as a trustee emeritus of princeton university tony is focused on building valuable companies that address important medical needs of the world while providing strong returns for investors tony received his ab in chemistry from princeton university and his phd in chemistry from the massachusetts institute of technology download headshot juno therapeutics adds jeff bezos venrock to m venture deal xconomy active companies constellation pharma — acceleron pharma — celladon corporation — cymabay therapeutics — aveo pharma — infinity pharma — alumni companies coley pharma — renovis — memory pharma — icagen — caliper — sonic innovations — triangle pharma — sugen — athena neurosciences — idec pharma — sepracor — idexx labs — centocor — genetics institute — genetics institute developed pharmaceuticals based on leading edge functional genomics technologies and proprietary disease models to treat a wide variety of human disease conditions download headshot back to top tony evnin  venrock active investments constellation pharma — private constellation pharmaceuticals discovers and develops novel drugs targeting selective regulators of epigenetic function acceleron pharma — public nasdaq xlrn acceleron is a biopharmaceutical company developing drugs for important unmet medical needs through proprietary approaches that exploit the therapeutic… celladon corporation — public nasdaq cldn celladon is developing a unique therapeutics platform to treat severe heart failure cymabay therapeutics — public otcqb cyma cymabay therapeutics discovers and develops small molecule drugs for the treatment of diabetes and related metabolic disorders aveo pharma — public nasdaq aveo aveo pharmaceuticals develops therapies for cancer using proprietary genetic model systems that enable the identification of essential targets critical… infinity pharma — public nasdaq infi infinity pharmaceuticals is a drug discovery company that is developing and integrating unique approaches and capabilities in synthetic chemistry chemical… alumni investments coley pharma — acquired by pfizer coley pharmaceutical group discovers develops and commercializes a new class of drugs that stimulate the human immune system to treat and prevent cancers… renovis — acquired by evotec renovis is a biopharmaceutical company focusing on neurological and psychiatric diseases and disorders using a combination of novel genomics and cellbased… memory pharma — acquired by roche memory pharmaceuticals develops small molecule therapeutics for memoryrelated neurological diseases and for psychiatric indications icagen — acquired by pfizer icagen discovers and develops small molecule therapeutics that target ion channels for treatment of a variety of diseases caliper — public nasdaq calp caliper life sciences develops microfluidic technologies to integrate complex laboratory procedures on a microchip for analytical instruments diagnostics… sonic innovations — acquired by william demant holding sonic innovations designs develops manufactures and markets advanced digital hearing aids designed to provide the highest levels of satisfaction for… triangle pharma — acquired by gilead triangle pharmaceuticals provided antiviral and oncology licensing sugen — acquired by pharmacia  upjohn sugen developed novel therapeutics through receptorbased approaches to drug discovery primarily involving kinases and phosphatases athena neurosciences — acquired by elan athena neurosciences manufactured diagnostic and therapeutic products for diseases of the nervous system idec pharma — acquired by biogen idec pharmaceuticals focuses on the commercialization and development of targeted therapies for the treatment of cancer and autoimmune diseases sepracor — public nasdaq sepr sepracor is a researchbased pharmaceutical company dedicated to treating and preventing human disease by discovering developing and commercializing… idexx labs — public nasdaq idxx … centocor — acquired by johnson  johnson centocor is an integrated biopharmaceutical company developing monoclonal antibodybased products for cardiovascular and autoimmune diseases cancer and… genetics institute — acquired by wyeth genetics institute developed pharmaceuticals based on leading edge functional genomics technologies and proprietary disease models to treat a wide variety of human disease conditions tony evnin partner focus areas biotechnology medical devices location new york focus areas biotechnology medical devices location new york tony joined venrock in  and built the firm’s healthcare franchise helping to shape the modern biotechnology industry he currently serves on the board of directors of two public companies aveo pharmaceuticals nasdaq aveo and infinity pharmaceuticals nasdaq infi as well as on the board of directors of constellation pharmaceuticals a private company past investments include acceleron nasdaq xlrn celladon nasdaq cldn centocor ipo acquired by johnson  johnson coley pharmaceutical group ipo acquired by pfizer genetics institute ipo acquired by wyeth icagen ipo acquired by pfizer idec pharmaceuticals ipo merged with biogen idexx laboratories nasdaq idxx millennium pharmaceuticals ipoacquired by takeda and sepracor ipoacquired by dainippon sumitomo more than  of his investments have been through an ipo during his venrock tenure tony started his career as a research scientist and group leader in organic chemistry at union carbide and as director of product development at story chemical he serves as a trustee of the rockefeller university as a trustee of the jackson laboratory as a member of the boards of overseers and managers of memorial sloankettering cancer center as a director of the new york genome center as a member of the board of directors of the albert and mary lasker foundation and as a trustee emeritus of princeton university tony is focused on building valuable companies that address important medical needs of the world while providing strong returns for investors tony received his ab in chemistry from princeton university and his phd in chemistry from the massachusetts institute of technology download headshot juno therapeutics adds jeff bezos venrock to m venture deal xconomy active companies constellation pharma — acceleron pharma — celladon corporation — cymabay therapeutics — aveo pharma — infinity pharma — alumni companies coley pharma — renovis — memory pharma — icagen — caliper — sonic innovations — triangle pharma — sugen — athena neurosciences — idec pharma — sepracor — idexx labs — centocor — genetics institute — genetics institute developed pharmaceuticals based on leading edge functional genomics technologies and proprietary disease models to treat a wide variety of human disease conditions download headshot back to top the rockefeller university » anthony b evnin phd skip to main content rockefeller university calendar clinical studies give search toggle button search submit anthony b evnin phd as a partner at the pathbreaking venture capital firm venrock anthony b evnin has helped to shape the modern biotechnology industry and profoundly influenced the course of translational research as an adviser and philanthropist he has also nurtured and advanced the translational efforts of the biomedical research community born and raised in new york city dr evnin received an ab from princeton university and a phd in chemistry from the massachusetts institute of technology he began his career as a research scientist and group leader in organic chemistry at union carbide and as director of product development at story chemical in  dr evnin joined venrock and he was there in  as the first investment opportunities in biotechnology were emerging focused on building valuable companies that address key medical needs he led venrock’s entrance into biotechnology and the greater life sciences field guiding its first  years of investments companies that benefited from his leadership and business acumen have included centocor idec pharmaceuticals infinity pharmaceuticals genetics institute idexx laboratories athena neurosciences acceleron pharma and more than  others he currently serves on the boards of directors of juno therapeutics aveo pharmaceuticals infinity pharmaceuticals cantel medical and constellation pharmaceuticals for three decades dr evnin has also supported rockefeller university in its mission first as a member of the rockefeller university council then as a member of the board of trustees to which he was elected in  he chaired the university’s technology transfer committee from its establishment in  until he retired from the board in  and he also served on the board’s scientific affairs and executive committees he was elected a trustee emeritus in  dr evnin now serves as a director of bridge medicines a leadingedge initiative recently launched by rockefeller and its triinstitutional partners memorial sloan kettering cancer center and weill cornell medicine to advance drug discovery projects from proof of principle to clinical development he is also a member of the boards of overseers and managers of memorial sloan kettering a trustee of the jackson laboratory a director of the new york genome center a member of the board of directors of the albert and mary lasker foundation and a trustee emeritus of princeton university infi anthony b evnin insider trades for infinity pharmaceuticals inc bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close infinity pharmaceuticals inc nasdaq infi go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus infinity pharmaceuticals inc after hours  quotes are delayed by  min jul    pm infi quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual anthony b evnin dr anthony b evnin is independent director at juno therapeutics inc lead independent director at infinity pharmaceuticals inc independent director at aveo pharmaceuticals inc partner at vr management llc partner at venrock associates a memberoverseers  managers board at memorial sloankettering cancer center and general partner at venrock management iii llc he is on the board of directors at juno therapeutics inc the jackson laboratory infinity pharmaceuticals inc aveo pharmaceuticals inc constellation pharmaceuticals inc the rockefeller university princeton university caliper technologies corp new york genome center and albert  mary lasker foundation dr evnin was previously employed as independent director by pharmos corp independent director by acceleron pharma inc an advisor by pelion venture partners independent director by neusentis inc a managerbusiness development by story chemical corp and research scientist by union carbide corp he also served on the board at pacific biosciences of california inc coley pharmaceutical group inc infinity discovery inc renovis inc syntonix pharmaceuticals inc memory pharmaceuticals corp sunesis pharmaceuticals inc altea therapeutics corp infinity energy resources inc athena neurosciences inc bostonpower inc celladon corp cymabay therapeutics inc genetics institute llc idexx laboratories inc kenet inc millennium pharmaceuticals inc sonic innovations inc and vela pharmaceuticals inc he received his undergraduate degree from princeton university and a doctorate degree from the massachusetts institute of technology transactions date shares transaction value     award at  per share      award at  per share      award at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share            copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives ms adelene q perkins chairman  chief executive officer dr lawrence e bloch president evp chief financial  business officer dr jeffery kutok chief scientific officer dr james r porter senior directorproduct development mr joseph f mcpherson vice presidentfacilities operations mr christopher m lindblom treasurer  vice presidentfinance mr jaren irene madden senior directorinvestor relations dr seth tasker secretary vice president  general counsel dr michael g kauffman independent director dr michael c venuti independent director dr josé baselga independent director mr jeffrey berkowitz independent director mr norman c selby independent director dr anthony b evnin lead independent director mr ian f smith independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest ayour next online order could be picked out by a robot a costly mistakes people make when buying cars awhat’s a cameo – like ed sheeran on game of thrones – actually worth ptrump says he has ‘complete power to pardon’ plawmakers reach deal on russia sanctions bill reports palphabet earnings a  billion hit for google potential youtube results for investors pyou can date someone who looks just like donald trump with this new online service pwant to buy happiness splurge on these  things pthis is what people really buy when they emotionally overspend hint it’s not designer clothes pjohn mccain is a war hero — but think twice before saying he’s ‘battling’ cancer pthe dark side of cruises pi want to buy my brothers out of our family home — but they want me to pay future sales fees poj simpson made over  while in prison and won’t have to give any of it to the goldman family pnot even free money can make some people go to the gym phow realestate tv shows determine what buyers look for in a house pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it pnote to parents this social network was rated the worst for teenage cyberbullying pif like sean spicer you suddenly quit your job — what should you do next pthis is the deadliest time of your life to put on weight p unfortunate reasons why millennials can’t have nice things or save any money loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  evnin anthony b  insider stock trading  openinsider sector all sectors group by sector aerospace agriculture automobile building business services chemical electrical energy fashion financial food  beverage fund healthcare household insurance machinery media metals mining other personal services real estate retail technology telecom transportation utility industry all industries group by industry insiders filings all purchases sales cik   address co  westlake avenue n ste  seattle wa   results links secyahoogooglefinviztradingviewstockchartsstocktwitsdownload csv tc stat stk ins fil d w m q h y avg pretpwinssretswins filing date t date ticker issuerinc sector indindustry owner ost rel title t tval price l qty oc own h ry ry rm rm rw rw rd rd fd fw fm fm fm fy  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bwadpd  cmdcantel medical corpdehealthmdeqsurgical  medical instrumentevnin anthony bnydpd  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bwadpd  cmdcantel medical corpdehealthmdeqsurgical  medical instrumentevnin anthony bnydpd  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bwadpd  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bcadsi  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bcadsmi  junojuno therapeutics incdehealthbioprdbiological products no diagevnin anthony bcadsmi  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bmadmdd  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bmadsi  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bnydsi  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bnydsmi  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bnydsmi  infiinfinity pharmaceuticals incdehealthdrugpharmaceutical preparationsevnin anthony bnydmdm  icgnicagen incdehealthdrugpharmaceutical preparationsevnin anthony bnydmdmm  parspharmos corpnvhealthdrugpharmaceutical preparationsevnin anthony bnydtpdi  icgnicagen incdehealthdrugpharmaceutical preparationsevnin anthony bnydpdi  memymemory pharmaceuticals corphealthdrugpharmaceutical preparationsevnin anthony bnydpdm  snsssunesis pharmaceuticals inchealthdrugpharmaceutical preparationsevnin anthony bnydpdi  memymemory pharmaceuticals corphealthdrugpharmaceutical preparationsevnin anthony bnydpdm  sncisonic innovations incdehealthorthoporthopedic prosthetic  surgevnin anthony bnydmdd  sncisonic innovations incdehealthorthoporthopedic prosthetic  surgevnin anthony bnydsi dderivative transaction in filing usually option exercise mmultiple transactions in filing earliest reported transaction date and weighted average transaction price aamended filing eerror detected in filing s  salesale of securities on an exchange or to another person s  saleoesale of securities on an exchange or to another person after option exercise f  taxpayment of exercise price or tax liability using portion of securities received from the company p  purchasepurchase of securities on an exchange or from another person return to top contact copyright   openinsidercom all rights reserved anthony evnin  venrock associates  zoominfocom anthony b evnin  greenwich ct  intelius sign in we found anthony b evnin in greenwich ct anthony b evnin intelius found that anthony b evnin is a male between  and  years old from greenwich ct we have connected them to  addresses  phones and  relatives or associates get report now age anthony b evnin is in his s anthony has lived in greenwich ct new york ny south san francisco ca anthonys relatives judy evnin b evnin luke evnin timothy evnin anthony b evnin zodiac signpisces gendermale professional status partner at venrock associates get report now want to know more about anthony get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about anthony or use our people search engine to find others get background check on anthony b evnin get a criminal check on anthony b evnin get a public record report on anthony b evnin get a people search report on anthony b evnin anthony b evnins contact information known cities lived in find out where anthony b evnin has lived as well as anthony b evnins phone numbers and email addresses anthony b evnin has lived in  states connecticut address for anthony b evnin  e m p r greenwich ct has lived in greenwich ct new york ny get full address report phone numbers associated with anthony b evnin    greenwich ct    greenwich ct    cambridge ma get full phone report email addresses associated with anthony b evnin ancom ancom aycom get email report anthony b evnins education information known schools attended learn about anthony b evnins academic history find out which schools anthony b evnin attended the dates attended as well as the degrees anthony b evnin received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act anthony b evnin has attended  schools massachusetts institute of technology anthony b evnin has a phd in chemistry princeton university  –  anthony b evnin has a bachelors degree in chemistry princeton university  –  anthony b evnin has a bachelors degree in chemistry princeton university  –  anthony b evnin has a bachelors degree chemistry in chemistry anthony b evnins professional information information regarding anthony b evnins professional history find out previous places anthony b evnin has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act anthony b evnin has worked at  places company venrock associates title partner company venrock associates title managing general partner anthony b evnins experience title partner company venrock associates job details originally established as the venture capital arm of the rockefeller family in  venrock partners with entrepreneurs to build some of the worlds most disruptive successful companies with a primary focus on technology and healthcare portfolio companies have included apple computer athenahealth centocor check point software doubleclick endeca gilead sciences idec pharma imperva illumina intel millennium pharma nest slideshare and tudou title managing general partner company venrock associates job details company size  mil to less than  mil  employee range  to less than  additional professional information on anthony b evnin see anthony b evnins linkedin profile anthony b evnins social network and potential email matches find out potential social network profiles and potential email usernamed for anthony b evnin anthony b evnins known social networks and potential email matches find all of anthony b evnins social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches anthony evnin username matches anthonyevnin evninanthony anthonyevnin evninanthony anthonyevnin evninanthony anthonyevnin evninanthony aevnin popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches a evnin intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here page not found  leadership directories products blogs about client support order return home     contact us toll free   broadway suite  new york ny  tel       fax    k street nw suite  washington dc  tel         fax   terms of use  privacy policy  faq  contact us  leadership directories inc evnin anthony b in greenwich  evnin anthony b  e middle patent rd greenwich ct  yahoo  us local homemailsearchnewssportsfinancecelebrityweatheranswersflickrmobilemorepoliticsmoviesmusictvgroupsstylebeautytechshopping yahoo local search sign in mail helpaccount infohelpsuggestionsyahoohomeadd a photoevnin anthony b reviews on yahoois this your business verify your listing e middle patent rd greenwich ct cross streets near the intersection of e middle patent rd and barn hill rdneighborhoods north stamford directionssend feedbackreviewswe currently dont have any reviews for evnin anthony bfind nearbyatms·hotels·night clubs·parkings·movie theatres· findevnin anthony blocal resourcesadd a businessbrowse by citystateadvertiser resourcesaccount centeradvertise with ussome business information provided by infogroup ® omaha nebraska copyright  privacyabout our adstermsaddedit businessyahoo maps terms of usehelpsend feedbackadditional terms of service